Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03886987 · ClinicalTrials.gov registry record · NA
Skin Sensitization Test (Modified Draize-95 Test)
A NA study of Skin Sensitisation, sponsored by Central Medicare Sdn. Bhd..
- Completed
- Registry status
- NA
- Development phase
- 245
- Enrollment target
- 1
- Study location
NCT03886987 is a NA study of Skin Sensitisation that has completed, run by Central Medicare Sdn. Bhd.. The registered enrollment target is 245 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03886987, a NA study of Skin Sensitisation, has completed, sponsored by Central Medicare Sdn. Bhd..
- COMPLETED
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
- 1
- Study location
Study Summary
Skin Sensitization Test (Modified Draize-95 Test) to Support a Low Dermatitis Potential Claim for a Blue Non Sterile Powder Free Nitrile Examination Gloves. This study is a RIPT (Repeat Insult Patch Test) to evaluate whether residual chemical additives at the level that may induce Type IV allergy in the nonsensitized general user population are present in a finished Blue Non Sterile Powder Free Nitrile Examination Glove.
Conditions Studied
Interventions
- DEVICE Blue Non Sterile Powder Free Nitrile Examination Gloves
Study Locations (1)
New Jersey
- Consumer Product Testing Company, Inc. - Fairfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2018-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03886987
The ClinicalTrials.gov registry entry for NCT03886987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Central Medicare Sdn. Bhd., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Sensitisation appearing as the primary indexed condition, and to 1 intervention - of which Blue Non Sterile Powder Free Nitrile Examination Gloves is the first listed.
NCT03886987 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03886987 about?
NCT03886987 is a clinical study titled "Skin Sensitization Test (Modified Draize-95 Test)". Skin Sensitization Test (Modified Draize-95 Test) to Support a Low Dermatitis Potential Claim for a Blue Non Sterile Powder Free Nitrile Examination Gloves. This study is a RIPT (Repeat Insult Patch Test) to evaluate whether residual chemical additives at the level that may induce Type IV allergy in...
What is the current status of trial NCT03886987?
This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2018-04-02. Estimated completion is 2018-06-08.
What conditions does trial NCT03886987 study?
This clinical trial studies the following conditions: Skin Sensitisation.
What interventions are being tested in trial NCT03886987?
The interventions under investigation include: Blue Non Sterile Powder Free Nitrile Examination Gloves (DEVICE).
Who is sponsoring clinical trial NCT03886987?
This trial is sponsored by Central Medicare Sdn. Bhd., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03886987 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.